Delivery Order SPE2DB22D2206-SPE2DB24FGK69
Award Date 4/1/24
Potential Completion Date 4/22/24
Potential Value $4K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply ORGOVYX 120 MG TABLET pharmaceuticals. The $7,979.34 contract has a performance period ending on March 28, 2024. Amerisourcebergen Drug Corp serves as the prime contractor for this delivery order, which is issued under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 with DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of ORGOVYX 120 MG TABLET UU 30S. This $7,979.34 order has a completion date of March 11, 2024 and does not utilize any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and holds a broader indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 to deliver pharmaceutical...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $3,989.67 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of ORGOVYX 120 MG TABLET UU 30S, a pharmaceutical product, with a completion date of March 22, 2024. AmerisourceBergen Drug Corp, a for-profit organization, serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $7,979.34 to Amerisourcebergen Drug Corp, a prime contractor and subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, which has an ultimate completion date of April 4, 2024, is for the delivery of ORGOVYX 120 MG TABLET pharmaceutical products. This award is part of Amerisourcebergen Drug Corp's broader portfolio of indefinite delivery contracts with DLA...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of ORGOVYX 120 mg tablets. The contract has a potential value of $1,329.89 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this contract to supply pharmaceuticals and medical supplies to support military treatment...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,659.78 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ORGOVYX 120 MG TABLET UU 30S, with a completion date of February 28, 2024. AmerisourceBergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is...
- The U.S. Defense Logistics Agency (DLA) awarded a $8,313.12 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is to deliver ORGOVYX 120 MG TABLET UU 30S, a pharmaceutical product, with a completion date of February 10, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
- The U.S. Defense Logistics Agency Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $3,989.67 firm fixed price delivery order contract to supply ORGOVYX 120 MG TABLET in a 30-count package. The contract has a completion date of February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds a larger $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical to provide a comprehensive range of...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply the pharmaceutical product ORGOVYX 120 MG TABLET. The contract, valued at $7,979.34, has an ultimate completion date of April 23, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the...
- This is a $1,385.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORGOVYX 120 MG TABLET, with a completion date of July 29, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FGK69Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,989.67 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply ORGOVYX 120 MG TABLET UU 30S pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that was awarded solely to AmerisourceBergen Drug Corp, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract has an ultimate completion date of April 22, 2024 and does not include any set-aside designations.
Generated 7/1/24, 9:16 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 4/1/24 |